Strongly criticized pharmaceutical company
References
- PRDpp. 25, 42–43, 59, 66, 71, 106–107, 123
- anonpp. 50, 77–78, 147, 149–150, 152
- Systempp. 31, 37–39, 52, 129, 148, 177, 240, 246, 252, 258, 285, 292, 296–297
Strongly criticized pharmaceutical company